The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,553

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664

All About Albumin: Biochemistry, Genetics, and Medical Applications

Peters, T. (1995) · Thammasat University Digital Collections · Cited by 3,089

Monoclonal Antibodies: Principles and Practice

Goding, J. W. (1996) · Cited by 903

Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells

Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 884

Metabolism of Immunoglobulins

Waldmann, T. A., & Strober, W. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000385919 · Cited by 731

An Fc receptor structurally related to MHC class I antigens

Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729

The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

Junghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 692

IgG Subclasses and Allotypes: From Structure to Effector Functions

Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667

FcRn: the neonatal Fc receptor comes of age

Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346

Signaling Mechanisms Regulating Endothelial Permeability

Mehta, D., & Malik, A. B. (2005) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,754

Hypoalbuminemia: Pathogenesis and Clinical Significance

Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448

The Discovery and Development of Liraglutide and Semaglutide

Knudsen, L. B., & Lau, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00155 · Cited by 970

Properties of mouse and human IgG receptors and their contribution to disease models

Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 905

Impact of albumin on drug delivery — New applications on the horizon

Elsadek, B., & Kratz, F. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 853

Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements

Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763

Albumin-based drug delivery: harnessing nature to cure disease

Larsen, M. T., Kuhlmann, M., Hvam, M. L., & Howard, K. A. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0048-8 · Cited by 704

Unraveling the mysteries of serum albumin—more than just a serum protein

Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00299 · Cited by 658

Follicular B helper T cells in antibody responses and autoimmunity

Vinuesa, C. G., Tangye, S. G., Moser, B., & Mackay, C. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1714 · Cited by 646

Mouse and human FcR effector functions

Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 607

Albumin as a versatile platform for drug half-life extension

Sleep, D., Cameron, J., & Evans, L. R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.023 · Cited by 510

Targeting receptor-mediated endocytotic pathways with nanoparticles: Rationale and advances

Xu, S., Olenyuk, B. Z., Okamoto, C. T., & Hamm‐Alvarez, S. F. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.041 · Cited by 476

Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters

Strohl, W. R. (2015) · BioDrugs · doi:10.1007/s40259-015-0133-6 · Cited by 479

Albumin and its application in drug delivery

Sleep, D. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 470

The Neonatal Fc Receptor (FcRn): A Misnomer?

Pyzik, M., Sand, K. M. K., Hubbard, J. J., Andersen, J. T., Sandlie, I., & Blumberg, R. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01540 · Cited by 450

Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins

Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428

Nutrient acquisition strategies of mammalian cells

Palm, W., & Thompson, C. B. (2017) · Nature · doi:10.1038/nature22379 · Cited by 388

Current issues in measurement and reporting of urinary albumin excretion

Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.106567 · Cited by 381

Clinical impact of serum proteins on drug delivery

Kratz, F., & Elsadek, B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.028 · Cited by 377

Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR

Suzuki, T., Ishii‐Watabe, A., Tada, M., Kobayashi, T., Kanayasu‐Toyoda, T., Kawanishi, T., & Yamaguchi, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903296 · Cited by 375

Albumin in decompensated cirrhosis: new concepts and perspectives

Bernardi, M., Angeli, P., Clària, J., Moreau, R., Ginès, P., Jalan, R., Caraceni, P., Fernández, J., Gerbes, A. L., O'Brien, A. J., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318843 · Cited by 367

Albumin and Mammalian cell culture: implications for biotechnology applications

Francis, G. L. (2010) · Cytotechnology · doi:10.1007/s10616-010-9263-3 · Cited by 376

Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease

Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J., Khabbaz, H. J. A., Brown, A. C., Presta, L. G., Meng, Y. G., & Roopenian, D. C. (2006) · International Immunology · doi:10.1093/intimm/dxl110 · Cited by 319

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases

Argyropoulos, C., Chen, S. S., Ng, Y., Roumelioti, M., Shaffi, S. K., Singh, P., & Tzamaloukas, A. H. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00073 · Cited by 324

Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics

Sand, K. M. K., Bern, M., Nilsen, J., Noordzij, H. T., Sandlie, I., & Andersen, J. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00682 · Cited by 304

Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis

Coppieters, K. T., Dreier, T., Silence, K., de Haard, H., Lauwereys, M., Casteels, P., Beirnaert, E., Jonckheere, H., de Wiele, C. V., Staelens, L., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21827 · Cited by 303

FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin

Pyzik, M., Räth, T., Lencer, W. I., Baker, K., & Blumberg, R. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403014 · Cited by 312

Lessons from the Crystallographic Analysis of Small Molecule Binding to Human Serum Albumin

Curry, S. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.342 · Cited by 302

Structural and biochemical features of human Serum albumin essential for eukaryotic cell culture

Mishra, V., & Heath, R. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168411 · Cited by 295

Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction

Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290

The therapeutic age of the neonatal Fc receptor

Pyzik, M., Kozicky, L. K., Gandhi, A. K., & Blumberg, R. S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00821-1 · Cited by 288

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential

Stapleton, N. M., Andersen, J. T., Stemerding, A. M., Bjarnarson, S. P., Verheul, R. C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., et al. (2011) · Nature Communications · doi:10.1038/ncomms1608 · Cited by 286

Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics

Räth, T., Baker, K., Dumont, J. A., Peters, R., Jiang, H., Qiao, S., Lencer, W. I., Pierce, G. F., & Blumberg, R. S. (2013) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.834293 · Cited by 289

Dependence of antibody-mediated presentation of antigen on FcRn

Qiao, S., Kobayashi, K., Johansen, F., Sollid, L. M., Andersen, J. T., Milford, E. L., Roopenian, D. C., Lencer, W. I., & Blumberg, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801717105 · Cited by 284

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

McDonagh, C. F., Huhalov, A., Harms, B. D., Adams, S., Paragas, V. B., Oyama, S., Zhang, B., Luus, L., Overland, R. P., Nguyen, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0820 · Cited by 278

Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism

Akilesh, S., Christianson, G. J., Roopenian, D. C., & Shaw, A. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4580 · Cited by 269

Podocytes use FcRn to clear IgG from the glomerular basement membrane

Akilesh, S., Huber, T. B., Wu, H. C., Wang, G., Hartleben, B., Kopp, J. B., Miner, J. H., Roopenian, D. C., Unanue, E. R., & Shaw, A. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711515105 · Cited by 261

The Proximal Tubule and Albuminuria

Dickson, L. E., Wagner, M. C., Sandoval, R. M., & Molitoris, B. A. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090950 · Cited by 266

Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms

Oganesyan, V., Damschroder, M. M., Cook, K. E., Li, Q., Gao, C., Wu, H., & Dall'Acqua, W. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.537563 · Cited by 259

Nanobodies as novel agents for cancer therapy

Revets, H., BAETSELIER, P. D., & Muyldermans, S. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.111 · Cited by 254

Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent

Dennis, M. S., Jin, H., Dugger, D. L., Yang, R., McFarland, L. M., Ogasawara, A. K., Williams, S. P., Cole, M. J., Ross, S., & SCHWALL, R. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2531 · Cited by 254

Nanomedicines for renal disease: current status and future applications

Kamaly, N., He, C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 256

Molecular engineering and design of therapeutic antibodies

Presta, L. G. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.012 · Cited by 256

Neonatal Fc Receptor: From Immunity to Therapeutics

Kuo, T. T., Baker, K., Yoshida, M., Qiao, S., Aveson, V. G., Lencer, W. I., & Blumberg, R. S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9468-4 · Cited by 258

Strategies to Extend Plasma Half-Lives of Recombinant Antibodies

Kontermann, R. E. (2009) · BioDrugs · doi:10.2165/00063030-200923020-00003 · Cited by 251

Neonatal Fc receptor and IgG-based therapeutics

Kuo, T. T., & Aveson, V. G. (2011) · mAbs · doi:10.4161/mabs.3.5.16983 · Cited by 243

Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin

Müller, D., Karle, A. C., Meißburger, B., Höfig, I., Stork, R., & Kontermann, R. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700820200 · Cited by 223

The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery

Bern, M., Sand, K. M. K., Nilsen, J., Sandlie, I., & Andersen, J. T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.006 · Cited by 224

Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice

Montoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211

Perspective – FcRn transports albumin: relevance to immunology and medicine

Anderson, C. L., Chaudhury, C., Kim, J., Bronson, C. L., Wani, M. A., & Mohanty, S. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.004 · Cited by 216

Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based model

Kim, J., Hayton, W. L., Robinson, J. M., & Anderson, C. L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2006.09.001 · Cited by 208

Stealth and pseudo-stealth nanocarriers

Wen, P., Ke, W., Dirisala, A., Toh, K., Tanaka, M., & Li, J. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114895 · Cited by 213

Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics

Schoch, A., Kettenberger, H., Mundigl, O., Winter, G., Engert, J., Heinrich, J., & Emrich, T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408766112 · Cited by 202

The Adaptable Major Histocompatibility Complex (MHC) Fold: Structure and Function of Nonclassical and MHC Class I–Like Molecules

Adams, E. J., & Luoma, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095912 · Cited by 210

Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding

Andersen, J. T., Daba, M. B., Berntzen, G., Michaelsen, T. E., & Sandlie, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081828 · Cited by 200

Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor

Andersen, J. T., Dalhus, B., Cameron, J., Daba, M. B., Plumridge, A., Evans, L. R., Brennan, S. O., Gunnarsen, K. S., Bjørås, M., Sleep, D., et al. (2012) · Nature Communications · doi:10.1038/ncomms1607 · Cited by 206

FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis

Vidarsson, G., Stemerding, A. M., Stapleton, N. M., Spliethoff, S. E., Janssen, H., Rebers, F. E. M., de Haas, M., & van de Winkel, J. G. J. (2006) · Blood · doi:10.1182/blood-2006-05-024539 · Cited by 203

The MHC class I-like Fc receptor promotes humorally mediated autoimmune disease

Akilesh, S., Petkova, S. B., Sproule, T. J., Shaffer, D. J., Christianson, G. J., & Roopenian, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18838 · Cited by 197

Tailoring anti-TNF therapy in IBD: drug levels and disease activity

Ben‐Horin, S., & Chowers, Y. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.253 · Cited by 192

Half‐Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation

van Witteloostuijn, S. B., Pedersen, S. L., & Jensen, K. J. (2016) · ChemMedChem · doi:10.1002/cmdc.201600374 · Cited by 194

Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia

Yamada, S., Tokumoto, M., Tatsumoto, N., Taniguchi, M., Noguchi, H., Nakano, T., Masutani, K., Ooboshi, H., Tsuruya, K., & Kitazono, T. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00633.2013 · Cited by 182

Battle of GLP-1 delivery technologies

Yu, M., Benjamin, M. M., Srinivasan, S., Morin, E. E., Shishatskaya, E. I., Schwendeman, S. P., & Schwendeman, A. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.009 · Cited by 192

Distribution of FcRn Across Species and Tissues

Latvala, S., Jacobsen, B., Otteneder, M. B., Herrmann, A., & Kronenberg, S. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417705095 · Cited by 179

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

Andersen, J. T., Pehrson, R., Максимилианович, Т. В., Daba, M. B., Abrahmsén, L., & Ekblad, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.164848 · Cited by 178

Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding

Andersen, J. T., Dalhus, B., Viuff, D., Ravn, B. T., Gunnarsen, K. S., Plumridge, A., Bunting, K., Antunes, F., Williamson, R., Athwal, S., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.549832 · Cited by 167

Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences

Wang, W., Lü, P., Fang, Y., Hamuro, L., Pittman, T. J., Carr, B. I., Hochman, J. H., & Prueksaritanont, T. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.039453 · Cited by 171

Genetic fusion to albumin improves the pharmacokinetic properties of factor IX

Weimer, T., Kronthaler, U. O., Lang, W., Schulte, S., & Metzner, H. J. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-04-0255 · Cited by 159

The Immunologic Functions of the Neonatal Fc Receptor for IgG

Räth, T., Kuo, T. T., Baker, K., Qiao, S., Kobayashi, K., Yoshida, M., Roopenian, D. C., Fiebiger, E., Lencer, W. I., & Blumberg, R. S. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9768-y · Cited by 162

Receptor-Mediated Endocytosis in the Proximal Tubule

Gliozzi, M. L., & Weisz, O. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034234 · Cited by 163

Albumin, a New Biomarker of Organophosphorus Toxicant Exposure, Identified by Mass Spectrometry

Peeples, E. S. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi023 · Cited by 159

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Cho, H., Jeon, S. I., Ahn, C., Shim, M. K., & Kim, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040728 · Cited by 163

Chapter 4 Multitasking by Exploitation of Intracellular Transport Functions

Ward, E. S., & Ober, R. J. (2009) · Advances in immunology · doi:10.1016/s0065-2776(09)03004-1 · Cited by 160

Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention

Patel, D. D., & Bussel, J. B. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.015 · Cited by 163

A review of lipidation in the development of advanced protein and peptide therapeutics

Menacho‐Melgar, R., Decker, J. S., Hennigan, J. N., & Lynch, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.032 · Cited by 159

Maternal IgG immune complexes induce food allergen–specific tolerance in offspring

Ohsaki, A., Venturelli, N., Buccigrosso, T. M., Osganian, S. K., Lee, J., Blumberg, R. S., & Oyoshi, M. K. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171163 · Cited by 151

The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy

Tao, H., Wang, R. L., Sheng, W., & Zhen, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.080 · Cited by 148

Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β 2 -microglobulin gene

Wani, M. A., Haynes, L. D., Kim, J., Bronson, C. L., Chaudhury, C., Mohanty, S., Waldmann, T. A., Robinson, J. M., & Anderson, C. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600548103 · Cited by 147

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes

Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146

Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces

Kim, J., Bronson, C. L., Hayton, W. L., Radmacher, M. D., Roopenian, D. C., Robinson, J. M., & Anderson, C. L. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00286.2005 · Cited by 145

An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions

Bteich, M. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02879 · Cited by 157

Boosting therapeutic potency of antibodies by taming Fc domain functions

Kang, T. H., & Jung, S. T. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0345-9 · Cited by 153

Albumin uptake and processing by the proximal tubule: physiological, pathological, and therapeutic implications

Molitoris, B. A., Sandoval, R. M., Yadav, S. P. S., & Wagner, M. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00014.2021 · Cited by 148

Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?

Nagelkerke, S. Q., & Kuijpers, T. W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00674 · Cited by 148

Derivatization with fatty acids in peptide and protein drug discovery

Kurtzhals, P., Østergaard, S., Nishimura, E., & Kjeldsen, T. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00529-w · Cited by 139

Albumin Is Recycled from the Primary Urine by Tubular Transcytosis

Tenten, V., Menzel, S., Kunter, U., Sicking, E.-M., van Roeyen, C. R. C., Sanden, S. K., Kaldenbach, M., Boor, P., Fuss, A., Uhlig, S., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010018 · Cited by 137

Targeting drug delivery in the vascular system: Focus on endothelium

Glassman, P. M., Myerson, J. W., Ferguson, L. T., Kiseleva, R. Y., Shuvaev, V. V., Brenner, J. S., & Muzykantov, V. R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.013 · Cited by 134

Albumin Nanovectors in Cancer Therapy and Imaging

Parodi, A., Miao, J., Soond, S. M., Rudzińska, M., & Zamyatnin, A. A. (2019) · Biomolecules · doi:10.3390/biom9060218 · Cited by 129

How functional foods play critical roles in human health

Pang, G., Xie, J., Chen, Q., & Zhi-he, H. (2012) · Food Science and Human Wellness · doi:10.1016/j.fshw.2012.10.001 · Cited by 134

Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn

Baker, K., Qiao, S., Kuo, T. T., Kobayashi, K., Yoshida, M., Lencer, W. I., & Blumberg, R. S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0160-9 · Cited by 134

Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity

Lorenz, M., Evers, A., & Wagner, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.022 · Cited by 129

Renal FcRn Reclaims Albumin but Facilitates Elimination of IgG

Sarav, M., Wang, Y., Hack, B. K., Chang, A., Jensen, M. A., Bao, L., & Quigg, R. J. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090976 · Cited by 126

The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics

Andersen, J. T., & Sandlie, I. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.318 · Cited by 124

The Role of FcRn in Antigen Presentation

Baker, K., Räth, T., Pyzik, M., & Blumberg, R. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00408 · Cited by 123

Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer

Porter, C., Armstrong-Fisher, S. S., Kopotsha, T., Smith, B., BAKER, T. S., Kevorkian, L., & Nesbitt, A. M. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.04.284 · Cited by 121

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders

Ward, E. S., Gelinas, D. F., Dreesen, E., Santbergen, J. V., Andersen, J. T., Silvestri, N. J., Kiss, J. E., Sleep, D., Rader, D. J., Kastelein, J. J. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.892534 · Cited by 133

Albumin, an interesting and functionally diverse protein, varies from ‘native’ to ‘effective’ (Review)

Wu, N., Liu, T., Tian, M., Liu, C., Ma, S., Cao, H., Bian, H., Wang, L., Feng, Y., & Qi, J. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13147 · Cited by 118

The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH‐dependent binding to albumin

Andersen, J. T., Qian, J. D., & Sandlie, I. (2006) · European Journal of Immunology · doi:10.1002/eji.200636556 · Cited by 123

Advances in Peptidomimetics for Next-Generation Therapeutics: Strategies, Modifications, and Applications

Lombardi, L., Genio, V. D., Alberício, F., & Williams, D. R. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00989 · Cited by 130

Perspective – FcRn transports albumin: relevance to immunology and medicine

Anderson, C. L., Chaudhury, C., Kim, J., Bronson, C. L., Wani, M. A., & Mohanty, S. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.004 · Cited by 216

The Influence of FcRn on Albumin-Fused and Targeted Drugs

Nilsen, J., Sand, K. M. K., Bern, M., Lei, P., Sandlie, I., & Andersen, J. T. (2016) · Springer eBooks · doi:10.1007/978-981-10-2116-9_10 · Cited by 1

The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics

Andersen, J. T., & Sandlie, I. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.318 · Cited by 124

An intact C-terminal end of albumin is required for its long half-life in humans

Nilsen, J., Trabjerg, E., Grevys, A., Azevedo, C., Brennan, S. O., Stensland, M., Wilson, J. J., Sand, K. M. K., Bern, M., Dalhus, B., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0903-7 · Cited by 82

Serum albumin and its interaction with the neonatal Fc receptor (FcRn) : characterization of the albumin/FcRn-binding mechanism

Färber-Schwarz, A. (2013) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-2165